Kymera Therapeutics, Inc. KYMR
119.39 USD -1.74 (-1.44%)
Regular-session close
119.39 0.00 0.00%
After hours · Nov 19, 4:39 PM ET
117.65 Day range 122.47
63.69 52-week range 142.92
- YTD
- +53.44%
- 1 year
- +84.19%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 39.21M | 47.07M | 78.59M | 46.83M | 72.83M | |
| 39.21M | 47.07M | 78.59M | 46.83M | 72.83M | |
| -349.40M | -261.63M | -165.53M | -161.26M | -100.53M | |
| -311.35M | -223.86M | -146.96M | -154.81M | -100.22M | |
| -3.69 | -2.98 | -2.52 | -2.87 | -2.09 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 362.81M | 126.05M | 115.78M | 74.53M | 54.09M | |
| 1.74B | 978.03M | 575.76M | 603.13M | 605.90M | |
| 163.15M | 142.42M | 180.79M | 112.98M | 146.27M | |
| 82.25M | 87.76M | 84.67M | 17.34M | 17.96M | |
| 1.58B | 835.62M | 394.97M | 490.15M | 459.64M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -232.89M | -194.50M | -102.83M | -153.09M | -128.95M | |
| -521.06M | -404.08M | 139.89M | 20.52M | -99.83M | |
| 990.71M | 608.85M | 4.19M | 153.00M | 250.28M | |
| -1.45M | -12.84M | -34.48M | -2.84M | -1.60M | |
| 236.76M | 10.27M | 41.25M | 20.43M | 21.50M |
